Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancerPaul A. Cohen, Michael Friedländer, Rachael L. Morton et al.|International Journal of Gynecological Cancer|2021Cited by 12
“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations.Rachel Campbell, Paul A. Cohen, Megan S Jeon et al.|Journal of Clinical Oncology|2025Cited by 0
CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancerPaul A. Cohen, M.L. Friedlander, Andreas Obermair et al.|Annals of Oncology|2025Cited by 0